Iron overload patients with unknown etiology from national survey in Japan
- PMID: 27848180
- DOI: 10.1007/s12185-016-2141-9
Iron overload patients with unknown etiology from national survey in Japan
Abstract
Transfusion is believed to be the main cause of iron overload in Japan. A nationwide survey on post-transfusional iron overload subsequently led to the establishment of guidelines for iron chelation therapy in this country. To date, however, detailed clinical information on the entire iron overload population in Japan has not been fully investigated. In the present study, we obtained and studied detailed clinical information on the iron overload patient population in Japan. Of 1109 iron overload cases, 93.1% were considered to have occurred post-transfusion. There were, however, 76 cases of iron overload of unknown origin, which suggest that many clinicians in Japan may encounter some difficulty in correctly diagnosing and treating iron overload. Further clinical data were obtained for 32 cases of iron overload of unknown origin; median of serum ferritin was 1860.5 ng/mL. As occurs in post-transfusional iron overload, liver dysfunction was found to be as high as 95.7% when serum ferritin levels exceeded 1000 ng/mL in these patients. Gene mutation analysis of the iron metabolism-related genes in 27 cases of iron overload with unknown etiology revealed mutations in the gene coding hemojuvelin, transferrin receptor 2, and ferroportin; this indicates that although rare, hereditary hemochromatosis does occur in Japan.
Keywords: Hemochromatosis; Hereditary hemochromatosis; Iron overload; Post-transfusional iron overload.
Similar articles
-
Epidemiology and diagnostic testing for hemochromatosis and iron overload.Int J Lab Hematol. 2015 May;37 Suppl 1:25-30. doi: 10.1111/ijlh.12347. Int J Lab Hematol. 2015. PMID: 25976957 Review.
-
Hemochromatosis and iron-overload screening in a racially diverse population.N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534. N Engl J Med. 2005. PMID: 15858186
-
Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.Transfusion. 2004 Jun;44(6):833-7. doi: 10.1111/j.1537-2995.2004.03264.x. Transfusion. 2004. PMID: 15157247
-
Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.Pathology. 2001 Feb;33(1):44-9. Pathology. 2001. PMID: 11280607
-
[Hemochromatosis--from an underdiagnosed curiosity to a common disease].Tidsskr Nor Laegeforen. 2009 Apr 30;129(9):863-6. doi: 10.4045/tidsskr.08.0084. Tidsskr Nor Laegeforen. 2009. PMID: 19415085 Review. Norwegian.
Cited by
-
Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.Pharmaceuticals (Basel). 2019 Sep 9;12(3):132. doi: 10.3390/ph12030132. Pharmaceuticals (Basel). 2019. PMID: 31505869 Free PMC article. Review.
-
Secondary Hemochromatosis Caused by Iron Overdose During Pregnancy and the Postpartum Period: A Case Report.Cureus. 2024 Jul 11;16(7):e64355. doi: 10.7759/cureus.64355. eCollection 2024 Jul. Cureus. 2024. PMID: 39130879 Free PMC article.
-
Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators.BMC Pediatr. 2022 Oct 29;22(1):622. doi: 10.1186/s12887-022-03706-3. BMC Pediatr. 2022. PMID: 36309641 Free PMC article.
-
Iron Overload and the Risk of Diabetes in the General Population: Results of the Chinese Health and Nutrition Survey Cohort Study.Diabetes Metab J. 2022 Mar;46(2):307-318. doi: 10.4093/dmj.2020.0287. Epub 2022 Mar 7. Diabetes Metab J. 2022. PMID: 35249273 Free PMC article.
-
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.Orphanet J Rare Dis. 2019 Jul 8;14(1):171. doi: 10.1186/s13023-019-1097-2. Orphanet J Rare Dis. 2019. PMID: 31286966 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials